Financials
- Market Capitalization 9.93 B
- Employee 273
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-21.09
Fiyat/satışlar oranı
167.66
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 924 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.73 USD | -1.34% | -0.81% | -3.38% | +98.59% | 10.02 B USD | ||
| 929 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 347.94 USD | -5.41% | -8.57% | +15.59% | +656.06% | 9.71 B USD | ||
| 957 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 144.03 USD | -3.66% | -4.92% | +5.21% | +91.71% | 9.32 B USD | ||
| 988 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.85 USD | 0.00% | +0.15% | +1.14% | +106.45% | 9.00 B USD |